1. Home
  2. ICUI vs PENN Comparison

ICUI vs PENN Comparison

Compare ICUI & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • PENN
  • Stock Information
  • Founded
  • ICUI 1984
  • PENN 1972
  • Country
  • ICUI United States
  • PENN United States
  • Employees
  • ICUI N/A
  • PENN N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • PENN Hotels/Resorts
  • Sector
  • ICUI Health Care
  • PENN Consumer Discretionary
  • Exchange
  • ICUI Nasdaq
  • PENN Nasdaq
  • Market Cap
  • ICUI 3.0B
  • PENN 2.8B
  • IPO Year
  • ICUI 1992
  • PENN 1994
  • Fundamental
  • Price
  • ICUI $123.69
  • PENN $17.72
  • Analyst Decision
  • ICUI Buy
  • PENN Buy
  • Analyst Count
  • ICUI 6
  • PENN 16
  • Target Price
  • ICUI $179.40
  • PENN $22.80
  • AVG Volume (30 Days)
  • ICUI 214.7K
  • PENN 3.3M
  • Earning Date
  • ICUI 11-06-2025
  • PENN 11-06-2025
  • Dividend Yield
  • ICUI N/A
  • PENN N/A
  • EPS Growth
  • ICUI N/A
  • PENN N/A
  • EPS
  • ICUI N/A
  • PENN N/A
  • Revenue
  • ICUI $2,372,504,000.00
  • PENN $6,745,700,000.00
  • Revenue This Year
  • ICUI N/A
  • PENN $8.36
  • Revenue Next Year
  • ICUI N/A
  • PENN $5.50
  • P/E Ratio
  • ICUI N/A
  • PENN N/A
  • Revenue Growth
  • ICUI 2.96
  • PENN 7.33
  • 52 Week Low
  • ICUI $107.00
  • PENN $13.25
  • 52 Week High
  • ICUI $196.26
  • PENN $23.08
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 55.19
  • PENN 48.33
  • Support Level
  • ICUI $119.74
  • PENN $17.60
  • Resistance Level
  • ICUI $124.17
  • PENN $18.28
  • Average True Range (ATR)
  • ICUI 3.35
  • PENN 0.60
  • MACD
  • ICUI 1.00
  • PENN 0.11
  • Stochastic Oscillator
  • ICUI 95.89
  • PENN 73.06

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About PENN PENN Entertainment Inc.

Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.

Share on Social Networks: